A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Active, not recruiting	Not stated	2026-02-04		NCT03193528

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cedars-Sinai Medical Center	161
Fred Hutchinson Cancer Center	123
Nara Medical University	3
Nara Prefecture Seiwa Medical Center	2
National Cancer Institute (NCI)	3015
Nonagen Bioscience Corporation	5
University of California, Los Angeles	355
University of Rochester	189
University of Texas	36

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cedars-Sinai Medical Center	Los Angeles	United States	392
Department of Urology, Nara Medical University	Nara	Japan	1
Nara Precfecture Seiwa Medical Center	Nara	Japan	1
University of California Los Angeles	Los Angeles	United States	87
University of Rochester Medical Center	Rochester	United States	2
UT Southwestern Medical Center at Dallas	Dallas	United States	5